Ana Urriola
Medical · Paterson, NJNPI 1235361106
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 437 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Novo Nordisk$995
- GSK$876
- Amgen$556
- AbbVie$515
- AstraZeneca$510
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,80298%
- Education$1262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 79 | $1,332 |
| Novo Nordisk | 77 | $995 |
| GSK | 62 | $876 |
| Amgen | 38 | $556 |
| AbbVie | 31 | $515 |
| AstraZeneca(2 entities) | 24 | $510 |
| Lilly USA, LLC | 31 | $420 |
| Boehringer Ingelheim | 14 | $313 |
| Astellas Pharma US Inc | 9 | $249 |
| Vivus LLC | 11 | $175 |
| Exact Sciences | 7 | $154 |
| Kowa Pharmaceuticals America, Inc. | 9 | $143 |
| Amarin Pharma, Inc. | 6 | $82 |
| Jazz Pharmaceuticals Inc. | 6 | $82 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| Madrigal Pharmaceuticals | 4 | $66 |
| Pfizer | 3 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Boston Scientific | 2 | $34 |
| Antares Pharma, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Phadia US Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Novartis | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,928 in reported general payments places this provider in the 90th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 95 | $100,561 |
| Xeljanz XrTofacitinib Citrate | 13 | $72,454 |
| MounjaroTirzepatide | 44 | $45,508 |
| JardianceEmpagliflozin | 32 | $31,920 |
| FarxigaDapagliflozin Propanediol | 26 | $27,746 |
| ProliaDenosumab | 13 | $22,863 |
| JanuviaSitagliptin Phosphate | 26 | $18,289 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $12,081 |
| Rosuvastatin Calcium | 121 | $1,968 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 12 | $1,760 |
| Mometasone Furoate | 12 | $1,132 |
| Atorvastatin Calcium | 63 | $993 |
| Lidocaine | 14 | $935 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $809 |
| Levocetirizine Dihydrochloride | 52 | $749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $995 | $100,56195 claims |
| Lilly USA, LLCMounjaro | $420 | $45,50844 claims |
| Boehringer IngelheimJardiance | $313 | $31,92032 claims |
| AstraZenecaFarxiga | $510 | $27,74626 claims |
| AmgenProlia | $556 | $22,86313 claims |
| GSKTrelegy Ellipta | $876 | $12,08119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 573 medical providers in New Jersey.
Other medical in Paterson
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
- Shane CourtneyLinwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.